NL-OMON50021招募中不适用
Establishing biomarkers and clinical endpoints in myotonic dystrophy type 1 (END-DM1) - Establishing biomarkers and clinical endpoints in DM type 1
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age 18 to 70 years (inclusive)
- •- Competent to provide informed consent
- •- Clinical diagnosis of DM1 based on research criteria or positive genetic test
排除标准
- •- Symptomatic renal or liver disease, uncontrolled diabetes or thyroid
- •disorder, or active malignancy other than skin cancer
- •- Current alcohol or substance abuse
- •- Concurrent enrollment in clinical trial for DM1, pr participation in trial
- •within 6 months of entry
- •- Concurrent pregnancy or planned pregnancy during the course of the study
- •- Concurrent medical condition that would, in the opinion of the investigator
- •or clinical evaluator, compromise performance on study measures
- •- Use of mexiletine or other anti-myotonia agents within 72 hours of baseline
- •Note: non-ambulatory participants are not excluded but are limited to <15% of
研究者
相似试验
招募中
不适用
Development of surrogate end-point biomarkers for chronic fatigue and myalgic encephalmyelitis/chronic fatigue syndrome ( ME/CFS)JPRN-UMIN000029076Osaka City University120
招募中
Unknown
Exploring Predictive and Prognostic Biomarkers in People with Cancer.Cancer - Any cancerCancerACTRN12623000853640Monash Health500
招募中
不适用
Identifying and validating predictive and prognostic biomarkers in male Germ Cell Tumours to improve the management and outcomes in both stage 1 and disseminated disease.Testicular cancerGerm Cell Tumour (GCT)Cancer - TesticularSeminomaACTRN12618000931279Walter and Eliza Hall Institute for Medical Research800
尚未招募
不适用
Biomarkers in Pancreatic CancerHistologically or cytologically confirmed pancreatic cancerCancer - PancreaticACTRN12616000519459The Walter and Eliza Hall Institute of Medical Research500
招募中
不适用
Clinical, molecular and functional biomarkers for PROgnosis, pathomechanisms and treatment strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)Coronavirus Disease 19 (COVID-19)U07.1J12J13J14J15J16J17J18COVID-19, virus identifiedViral pneumonia, not elsewhere classifiedPneumonia due to Streptococcus pneumoniaePneumonia due to Haemophilus influenzaeBacterial pneumonia, not elsewhere classifiedPneumonia due to other infectious organisms, not elsewhere classifiedPneumonia in diseases classified elsewherePneumonia, organism unspecifiedDRKS00022871CAPNETZ STIFTUNG, Geschäftsstelle an der Medizinischen Hochschule Hannover400